Lck Inhibitor III
1188890-30-3
|
Lck inhibitor 2
944795-06-6
|
Lck inhibitor II
918870-43-6
|
Lck-IN-1
923596-52-5
|
APR-246
5291-32-7
|
4,4'-methylenebis[3-hydroxy-2-naphthoic] acid, compound with 10-[2-(dimethylamino)propyl]phenothiazine
24561-61-3
|
plutonium-246
15756-66-8
|
(3R,3'S)-5-chloro-6',7'-difluoro-3'-methylspiro[1H-indole-3,1'-2,3,4,9-tetrahydropyrido[3,4-b]indole]-2-one
1193314-71-4
|
americium-246
15776-16-6
|
5,8-Dichloro-4-(piperazin-1-yl)-2-propylquinoline hydrochloride
1333258-46-0
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
tert-Butyl-DL-alanine
1375289-11-4
|
3-{[1-(4-Phenyloxane-4-carbonyl)piperidin-4-yl]methyl}-3,4-dihydroquinazolin-4-one
2380185-30-6
|
